Active	Status	Sponsor type	Region	Phase	Filter
4 Active 30 Inactive 34 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Stupica, Daša
NCT03462329: Patient's Pretreatment Expectations About Post-Lyme Symptoms	Recruiting	N/A	200	Europe	Antibiotics (preferentially oral doxycycline 100 mg bid)	University Medical Centre Ljubljana	Erythema Migrans	12/24	12/24
NCT03956446: Tick-borne Encephalitis and Borrelial Antibodies in Serum	Recruiting	N/A	80	Europe	Doxycycline, Symptomatic therapy, Questionnaire	University Medical Centre Ljubljana, University of Ljubljana School of Medicine, Slovenia	Tick Borne Encephalitis	12/24	12/24
NCT03966014: Different Amoxicillin Treatment Regimens in Erythema Migrans Patients	Recruiting	N/A	510	Europe	EM-amoxicillin 3 x 10 days, EM-amoxicillin 3 x 14 days, EM-amoxicillin 2 x 14 days, Controls	University Medical Centre Ljubljana, University of Ljubljana School of Medicine, Slovenia	Erythema Migrans	12/25	12/25
NCT03337932: Duration of Doxycycline Treatment in MEM Patients	Recruiting	N/A	200	Europe	Doxycycline 100 milligram Oral Tablet bid, 7 days, Doxycycline 100 milligram Oral Tablet bid, 14 days, Controls without a history of lyme disease.	University Medical Centre Ljubljana	Erythema Chronicum Migrans	12/24	12/24